Top > Find a Doctor > Takashi Moritoyo

Takashi Moritoyo

Takashi Moritoyo
Departments/Divisions

Clinical Research Support Center

Titles

M.D. , Ph.D.

Expertise/Specialties

Clinical Pharmacology, Neurology

Research Interests

Clinical Pharmacology, Neurology

Languages

Japanese, English

HomePage

http://www.h.u-tokyo.ac.jp/english/centers-services/central-clinical-facilities/clinical-research-support-center/index.html

Education
Year Institution Degree
1986 Kagoshima University Faculty of Medicine M.D.
1987 Kagoshima University Faculty of Medicine Ph.D.
Training
Years attended Institution Training
1986 Kagoshima University Faculty of Medicine Internship
1992 Department of Microbiology, University of Minnesota Postdoctoral Associate
Appointments and positions
Years Institution Title
2003-2010 Clinical Therapeutic Research Center, Ehime University Hospital Associate Professor
2010-2012 Office of New Drug II & III, Pharmaceuticals & Medical Devices Agency Deputy Review Director
2012-2015 Phase 1 Unit, Clinical Research Support Center, The University of Tokyo Hospital Project Associate Professor
2015-2018 Department of Clinical Research Governance, The University of Tokyo Hospital Project Professor
2018 Clinical Research Support Center, The University of Tokyo Hospital Professor
Board Certifications
Year Certifications
1992



Japanese Society of Neurology Board Certified Neurologist
2010 The Japanese Society of Clinical Pharmacology and Therapeutics Board Certified Clinical Pharmacologist
Selected Publications
  • Moritoyo T., Reinhart T.A., Moritoyo H., Sato E., Izumo S., Osame M., Haase A.T. Human T-lymphotropic virus type I-associated myelopathy and tax gene expression in CD4+ T lymphocytes. Ann. Neurol. 40:84-90, 1996
  • Moritoyo T. Accelerating Regulatory Science Initiatives for the Development of Drugs for Alzheimer’s Disease in Japan. Clin. Ther. 37:1622-1626, 2015
Academic Societies
  • Japanese Society of Neurology
  • American Academy of Neurology
  • The Japanese Society of Clinical Pharmacology and Therapeutics

page top